A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics

PURPOSE: Oral cannabinoids (i.e., dronabinol, nabilone) containing the active component of marijuana, delta(Δ)9-tetrahydrocannabinol (THC), are available for the treatment of chemotherapy-induced nausea and vomiting (CINV) in patients with cancer who have failed to adequately respond to conventional...

Descripción completa

Detalles Bibliográficos
Autor principal: Badowski, Melissa E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573753/
https://www.ncbi.nlm.nih.gov/pubmed/28780725
http://dx.doi.org/10.1007/s00280-017-3387-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573753/
https://www.ncbi.nlm.nih.gov/pubmed/28780725
http://dx.doi.org/10.1007/s00280-017-3387-5

Ejemplares similares